The many roles for fluorine in medicinal chemistry

被引:3148
作者
Hagmann, William K. [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
关键词
D O I
10.1021/jm800219f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One cannot overestimate the profound influence that organofluorine chemistry has had on drug discovery. The ever increasing array of commercially available fluorinated starting materials coupled with novel and imaginative synthetic methodologies offers to the medicinal chemist broad opportunities to positively influence the direction and timelines in a drug discovery program. Medicinal chemists should approach the various structure-activity relationships that may need to be addressed with a keen understanding of the potential that selective fluorination may afford. That potential may be realized in solving issues as different as changes in solubility, CNS penetration, metabolic stability, or improvements in potency. A greater appreciation of the role(s) that fluorine substitution can have on the physicochemical properties in a molecule gives the medicinal chemist more strategies to solve some of their challenges in a drug discovery program. Hopefully, this Perspective and the few cited examples will provide incentives to further explore the opportunities in organofluorine chemistry as it relates to medicinal chemistry and drug discovery. © 2008 American Chemical Society.
引用
收藏
页码:4359 / 4369
页数:11
相关论文
共 83 条
  • [11] METHYL FLUOROSULFONYLDIFLUOROACETATE - A NEW TRIFLUOROMETHYLATING AGENT
    CHEN, QY
    WU, SW
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1989, (11) : 705 - 706
  • [12] DIASTEREOSELECTIVE FLUORINATION OF CHIRAL IMIDE ENOLATES USING N-FLUORO-O-BENZENEDISULFONIMIDE (NFOBS)
    DAVIS, FA
    HAN, W
    [J]. TETRAHEDRON LETTERS, 1992, 33 (09) : 1153 - 1156
  • [13] Dean J.A., 2001, Lange's Handbook of Chemistry, V15
  • [14] The strength of weak interactions: Aromatic fluorine in drug design
    DiMagno, Stephen G.
    Sun, Haoran
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (14) : 1473 - 1482
  • [15] Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs
    Doan, KMM
    Humphreys, JE
    Webster, LO
    Wring, SA
    Shampine, LJ
    Serabjit-Singh, CJ
    Adkison, KK
    Polli, JW
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) : 1029 - 1037
  • [16] Potent and selective proline derived dipeptidyl peptidase IV inhibitors
    Edmondson, SD
    Mastracchio, A
    Beconi, M
    Colwell, LF
    Habulihaz, B
    He, HB
    Kumar, SJ
    Leiting, B
    Lyons, KA
    Mao, A
    Marsilio, F
    Patel, RA
    Wu, JK
    Zhu, L
    Thornberry, NA
    Weber, AE
    Parmee, ER
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) : 5151 - 5155
  • [17] Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development
    Evans, DC
    Watt, AP
    Nicoll-Griffith, DA
    Baillie, TA
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) : 3 - 16
  • [18] Titanium-catalyzed stereoselective geminal heterodihalogenation of β-ketoesters
    Frantz, R
    Hintermann, L
    Perseghini, M
    Broggini, D
    Togni, A
    [J]. ORGANIC LETTERS, 2003, 5 (10) : 1709 - 1712
  • [19] SYNTHESIS OF 17-ALPHA-HYDROXYCORTICOSTERONE AND ITS 9-ALPHA-HALO DERIVATIVES FROM 11-EPI-17-ALPHA-HYDROXYCORTICOSTERONE
    FRIED, J
    SABO, EF
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1953, 75 (09) : 2273 - 2274
  • [20] A facile synthesis of trifluoromethyl- and 3,3,3-trifluoropropenyl-substituted aromatic compounds by the oxidative desulfurization-fluorination of the corresponding carbodithioates
    Furuta, S
    Kuroboshi, M
    Hiyama, T
    [J]. BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1999, 72 (04) : 805 - 819